Summit Cancer Centers is very happy to welcome Dr. Raj Rajendra to our Medical Oncology team. Summit Cancer Centers is proud to announce that Dr. Raj Rajendra has joined our Medical Oncology team. Dr. Raj is currently practicing at the Post Falls cancer center. About Raj Rajendra, MD Dr. Rajeev Rajendra, or “Dr. Raj” as…
Read more Share

Welcome Dr. Janelle Bennett to Summit’s Medical Oncology team. Summit Cancer Centers is proud to introduce Dr. Janelle Bennett as a member of the Medical Oncology team. Dr. Bennett is currently seeing patients at our Spokane Valley cancer center. About Janelle Bennett, MD Dr. Janelle Bennett is a Spokane native and attended…
Read more Share

Summit Cancer Centers is proud to welcome Dr. Linda Grossheim to our Radiation Oncology team. Summit Cancer Center is proud to announce that Dr. Linda Grossheim has joined our Radiation Oncology team. Dr. Grossheim will practice at our Post Falls cancer center beginning September 2018. About Linda Grossheim, MD Linda Grossheim,…
Read more Share

Summit Cancer Centers is very pleased to welcome Dr.  Aaron Saunders to  our care team. Summit Cancer Center is pleased to announce that Dr. Aaron Saunders has joined our Surgical Oncology staff. Dr. Saunders will provide care at our Spokane Valley cancer center. About Aaron Saunders, MD Dr. Saunders specializes in…
Read more Share

Summit Cancer Centers is First in the Inland Northwest to Obtain a New Generation of Dual Immunotherapy Trials for First Line Metastatic Non-Small Cell Lung Cancer. Immunotherapy has revolutionized the treatment of metastatic non-small cell lung cancer. However, not every patient responds to single agent immunotherapy, either alone or in…
Read more Share

Summit Cancer Centers is first in Washington to offer the Phase 3 Clinical Trial of Immunotherapy AM0010 for Metastatic Adenocarcinoma of the Pancreas. “We are proud to offer an immunotherapy trial for advanced adenocarcinoma of the pancreas,” states Dr. Arvind Chaudhry, Director of Research at Summit Cancer Centers. Current treatments…
Read more Share

Summit Cancer Centers is first in the nation to offer Duvelisib, a new Lymphoma drug trial for patients with CLL who have experienced relapse on Ibrutinib. FDA approval of Imbruvica (ibrutinib) in February of 2014 revolutionized the treatment and outcome of patients with chronic lymphocytic lymphoma (CLL). Median survival rates of…
Read more Share

Summit Cancer Centers are  first in Spokane to offer a powerful new dual immunotherapy clinical trial in the treatment of advanced kidney cancer. The significant challenge with kidney cancer is that patients are often diagnosed at an advanced stage, and therefore, are very sick at their initial clinical visit. “We wanted options…
Read more Share

Summit Cancer Center is proud to be the first in a six state region to molecularly target a resistant form of colorectal cancer. Colorectal cancers with BRAF mutations have long been known to be resistant, or quickly recur, following conventional chemotherapy. Array Biopharma is testing a molecular combination that specifically…
Read more Share

Dr. Arvind Chaudhry was recently invited by Bayer to educate physicians on the new lymphoma therapy, Aliqopa. Dr. Arvind Chaudhry, medical oncologist and medical director of Summit Cancer Centers, was recently invited to educate physicians on the FDA approval of the follicular lymphoma drug, Aliqopa (copanlisib). Aliqopa belongs to a new class of drugs that…
Read more Share